Author

D. Uthayakumar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:C. elegans· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

R. S. Shapiro· 3 shared A. A. La Bella· 1 shared A. Chavez· 1 shared A. L. Flores-Mireles· 1 shared C. Grant· 1 shared C. J. Brandl· 1 shared C. Landry· 1 shared D. Francis· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

R. S. Shapiro

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A role for the putative error-prone polymerase REV1 in DNA damage and antifungal drug resistance in Candida albicans

M. R. Agyare-Tabbi, D. Uthayakumar, D. Francis, L. Maroc, C. Grant, P. McQueen, G. Westmacott, H. Shaker, I. Skulska, I. Gagnon-Arsenault, J. Boisvert, C. Landry, R. S. Shapiro

This study investigates the role of REV1, an error-prone polymerase, in DNA damage and antifungal drug resistance in Candida albicans, finding that its deletion increases mutation rates and resistance.

bioRxiv · Jun 24, 2024 · PreprintMicrobiology

Development and applications of a CRISPR activation system for facile genetic overexpression in Candida albicans

N. C. Gervais, A. A. La Bella, L. F. Wensing, J. Sharma, V. Acquaviva, M. Best, R. O. Cadena Lopez, M. Fogal, D. Uthayakumar, A. Chavez, F. Santiago-Tirado, A. L. Flores-Mireles, R. S. Shapiro

This paper develops a CRISPR activation system for genetic overexpression in Candida albicans and demonstrates its ability to drive high-level gene expression and identify novel phenotypes.

bioRxiv · Aug 15, 2022Microbiology

The SAGA and NuA4 component Tra1 regulates Candida albicans drug resistance and pathogenesis

I. Razzaq, M. D. Berg, Y. Jiang, J. Genereaux, D. Uthayakumar, G. H. Kim, C. J. Brandl, P. Lajoie, R. S. Shapiro

This study identifies Tra1 as a key regulator of drug resistance and pathogenesis in Candida albicans by analyzing gene expression and mutant phenotypes.

bioRxiv · Mar 17, 2021Microbiology